Pharmacokinetics and Safety of Extemporaneously Compounded Valacyclovir Oral Suspension in Pediatric Patients from 1 Month through 11 Years of Age
Open Access
- 15 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 50 (2) , 221-228
- https://doi.org/10.1086/649212
Abstract
Background. Valacyclovir provides enhanced acyclovir bioavailability in adults, but limited data are available in children.Methods. Children 1 month tKeywords
This publication has 1 reference indexed in Scilit:
- Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and VidarabineThe Journal of Infectious Diseases, 1992